GZMO, Kirin antibody deal

Genzyme Molecular (GZMO) and Kirin Brewery (Tokyo, Japan) partnered to develop and market human monoclonal antibodies for cancer. Kirin will use its KM mouse technology to make antibodies against GZMO...